Read what the media has been reporting on Atlantic PATH and the Canadian Partnership for Tomorrow Project.
The latest CanPath newsletter highlights new research on mental health service use and COVID-19, rural communities facing higher risks of lung cancer from radon, Colorectal Cancer Awareness Month, and updates from all the regional cohorts. The Atlantic PATH team continues to work remotely to support access requests for researchers for baseline, follow-up and COVID-19 questionnaire Read more about CanPath Newsletter[…]
CanPath was featured as one of Canada’s most successful investments in biobanking! 🩸💉 In an Open Access Government article, Francois Lamontagne, Paul Hebert, and Michelle Kho (Sepsis Canada) emphasize the critical role of biobanks in generating new insights into healthcare and disease management. They underscore the pitfalls of ‘classic’ biobanks, highlight the low-cost opportunity of ‘living’ biobank Read more about CanPath Featured as one of Canada’s Most Successful Investments in Biobanking[…]
A new article has been published in Scientific Reports on the progress in site-specific cancer mortality in Canada over the last 70 years. Using data from Statistics Canada and the Global Cancer Observatory, Warkentin et al. (2024) found that there has been “a significant reduction in cancer mortality in Canada since site-specific cancer mortality rates peaked Read more about New Article on Progress in Site-Specific Cancer Mortality[…]
Join CanPath for an informative session on accessing CanPath data and biosamples for your research projects! Whether you’re a seasoned researcher or new to the process, our Access Office experts are here to provide insider tips on ensuring your application is successful. The “Access Office Hours” virtual series provides researchers with an opportunity every quarter to ask Read more about CanPath Access Office Hours[…]
Type 2 diabetes (T2D) is a widespread chronic condition with severe consequences, including complications affecting blood vessels and organs, disability, and premature death. Research indicates that depression can significantly raise the risk of developing T2D, potentially through lifestyle and biological factors. Additionally, our modern diet presents a challenge with the increasing consumption of ultra-processed foods Read more about Upcoming CanPath Webinar on Ultra-processed food consumption, depression, and diabetes[…]
Research conducted using CanPath data, including Atlantic PATH found that at least one in five lung cancer cases diagnosed are found in people who have never smoked. Our colleague, Dr. Aaron Goodarzi has written a new article on the risks of lung cancer that rural communities face as a result of exposure to radon. Full article: https://troymedia.com/health/cancer-risk-from-radon-gas-is-higher-in-rural-communities/
We are pleased to share that a new publication from the Psychosocial Factors and Cancer Incidence (PSY-CA) consortium have been published in Cancer Epidemiology. Led from the Netherlands by Dr. Lonneke van Tuijl and Dr. Joost Dekker, this study includes 18 cohorts with more than 300,000 participants including Atlantic PATH, the Ontario Health Study and CARTaGENE from CanPath. Our local team members include Mr. Read more about New Publication – Psychosocial factors, health behaviors and risk of cancer incidence[…]
How does our environment (ex. green spaces, walkability, light at night, air pollution) impact our risk of breast, prostate, lung, and colorectal cancers? And, could the information in our blood, combined with details about our health and lifestyle, help predict the risk of developing breast cancer in the future? 🌱🔬 Join us on Monday, January Read more about Upcoming @CanPath Trainee Webinar on the built environment, metabolites and cancer risk[…]
Dr. John Lewis is a Professor in the Department of Oncology at the University of Alberta and the Bird Dogs Chair in Translational Oncology. Dr. Lewis’ research interests include translational prostate cancer research, and the Lewis Lab utilizes real-time intravital imaging of the tumour microenvironment to learn about the critical steps of cancer progression, including the growth of new Read more about Dr. John Lewis at #CCRC2023[…]
Dr. Trevor Dummer will be attending the Canadian Cancer Research Conference. Dr. Dummer is the co-Scientific Director for CanPath, an Associate Professor at the School of Population and Public Health at the University of British Columbia, the Canadian Cancer Society Chair in Primary Prevention, and Affiliated Scientist, BC Cancer. Dr. Dummer’s research interests include how the Read more about Dr. Trevor Dummer and Mohadeseh Ahmadi at #CCRC2023[…]